Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2176862rdf:typepubmed:Citationlld:pubmed
pubmed-article:2176862lifeskim:mentionsumls-concept:C1135183lld:lifeskim
pubmed-article:2176862lifeskim:mentionsumls-concept:C0027950lld:lifeskim
pubmed-article:2176862lifeskim:mentionsumls-concept:C0025519lld:lifeskim
pubmed-article:2176862lifeskim:mentionsumls-concept:C0015684lld:lifeskim
pubmed-article:2176862lifeskim:mentionsumls-concept:C0001128lld:lifeskim
pubmed-article:2176862lifeskim:mentionsumls-concept:C0030016lld:lifeskim
pubmed-article:2176862lifeskim:mentionsumls-concept:C1704259lld:lifeskim
pubmed-article:2176862lifeskim:mentionsumls-concept:C1705987lld:lifeskim
pubmed-article:2176862pubmed:issue43lld:pubmed
pubmed-article:2176862pubmed:dateCreated1991-2-22lld:pubmed
pubmed-article:2176862pubmed:abstractTextWe have previously shown that porcine polymorphonuclear leukocytes (PMNL) reduce leukotriene B4 (LTB4) to 10,11-dihydro-LTB4, 10,11-dihydro-12-epi-LTB4, and 10,11-dihydro-12-oxo-LTB4 [Wainwright et al. (1990) Biochemistry 29, 1180-1185]. We have now demonstrated that 12(S)-hydroxy-5,8,10,14-eicosatetraenoic acid [12(S)-HETE] is metabolized by a similar pathway in porcine PMNL. 12(S)-HETE was metabolized to two products that were identified by gas chromatography-mass spectrometry and nuclear magnetic resonance spectroscopy as 12-hydroxy-5,8,14-eicosatrienoic acid (10,11-dihydro-12-HETE) and 12-oxo-5,8,14-eicosatrienoic acid (10,11-dihydro-12-oxo-ETE). Derivatization of 12-hydroxy-5,8,14-eicosatrienoic acid with (R)-(+)-alpha-methoxy-alpha-(trifluoromethyl)phenylacetic acid, followed by chromatography on a silicic acid column, enabled the resolution of 12R and 12S stereoisomers, which were identified by cochromatography with synthetic standards. Incubation of 12(S)-HETE with PMNL for various times revealed that the stereochemistry of the 12-hydroxyl group of 12-hydroxy-5,8,14-eicosatrienoic acid was initially the same as that of 12(S)-HETE. However, after 40 min, 30% of the 12-hydroxy-5,8,14-eicosatrienoic acid had the opposite configuration at C12. 13-Hydroxy-9,11-octadecadienoic acid (13-HODE) was metabolized in a similar fashion by porcine PMNL to 13-hydroxy-9-octadecenoic acid (11,12-dihydro-13-HODE) and 13-oxooctadecenoic acid (11,12-dihydro-13-oxo-ODE). The apparent Km values for the reduction of 12-HETE, LTB4, and 13-HODE were 0.21, 0.28, and 2.22 microM, respectively. All three substrates had the same apparent Vmax [0.029 pmol min-1 (10(6) cells)-1]. Competition experiments between LTB4 and 12-HETE indicated that they were metabolized by the same pathway. Various structurally related compounds were metabolized by porcine PMNL in the order LTB4 = 6-trans-LTB4 greater than 12-epi-6-trans,8-cis-LTB4 greater than 12-epi-6-trans-LTB4 greater than 12-HETE greater than LTB5 greater than 15-HETE = 13-HODE much greater than 5-HETE greater than 9-HODE greater than 20-hydroxy-LTB4 greater than 12-hydroxy-5,8,10-heptadecatrienoic acid. Prostaglandins E2 and F2 alpha were not metabolized to any detectable products by porcine PMNL.lld:pubmed
pubmed-article:2176862pubmed:languageenglld:pubmed
pubmed-article:2176862pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2176862pubmed:citationSubsetIMlld:pubmed
pubmed-article:2176862pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2176862pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2176862pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2176862pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2176862pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2176862pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2176862pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2176862pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2176862pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2176862pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2176862pubmed:statusMEDLINElld:pubmed
pubmed-article:2176862pubmed:monthOctlld:pubmed
pubmed-article:2176862pubmed:issn0006-2960lld:pubmed
pubmed-article:2176862pubmed:authorpubmed-author:PowellW SWSlld:pubmed
pubmed-article:2176862pubmed:authorpubmed-author:WainwrightSSlld:pubmed
pubmed-article:2176862pubmed:authorpubmed-author:FalckJ RJRlld:pubmed
pubmed-article:2176862pubmed:authorpubmed-author:YadagiriPPlld:pubmed
pubmed-article:2176862pubmed:issnTypePrintlld:pubmed
pubmed-article:2176862pubmed:day30lld:pubmed
pubmed-article:2176862pubmed:volume29lld:pubmed
pubmed-article:2176862pubmed:ownerNLMlld:pubmed
pubmed-article:2176862pubmed:authorsCompleteYlld:pubmed
pubmed-article:2176862pubmed:pagination10126-35lld:pubmed
pubmed-article:2176862pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:2176862pubmed:meshHeadingpubmed-meshheading:2176862-...lld:pubmed
pubmed-article:2176862pubmed:meshHeadingpubmed-meshheading:2176862-...lld:pubmed
pubmed-article:2176862pubmed:meshHeadingpubmed-meshheading:2176862-...lld:pubmed
pubmed-article:2176862pubmed:meshHeadingpubmed-meshheading:2176862-...lld:pubmed
pubmed-article:2176862pubmed:meshHeadingpubmed-meshheading:2176862-...lld:pubmed
pubmed-article:2176862pubmed:meshHeadingpubmed-meshheading:2176862-...lld:pubmed
pubmed-article:2176862pubmed:meshHeadingpubmed-meshheading:2176862-...lld:pubmed
pubmed-article:2176862pubmed:meshHeadingpubmed-meshheading:2176862-...lld:pubmed
pubmed-article:2176862pubmed:meshHeadingpubmed-meshheading:2176862-...lld:pubmed
pubmed-article:2176862pubmed:meshHeadingpubmed-meshheading:2176862-...lld:pubmed
pubmed-article:2176862pubmed:meshHeadingpubmed-meshheading:2176862-...lld:pubmed
pubmed-article:2176862pubmed:meshHeadingpubmed-meshheading:2176862-...lld:pubmed
pubmed-article:2176862pubmed:meshHeadingpubmed-meshheading:2176862-...lld:pubmed
pubmed-article:2176862pubmed:meshHeadingpubmed-meshheading:2176862-...lld:pubmed
pubmed-article:2176862pubmed:year1990lld:pubmed
pubmed-article:2176862pubmed:articleTitleMetabolism of 12(S)-hydroxy-5,8,10,14-eicosatetraenoic acid and other hydroxylated fatty acids by the reductase pathway in porcine polymorphonuclear leukocytes.lld:pubmed
pubmed-article:2176862pubmed:affiliationEndocrine Laboratory, Royal Victoria Hospital, Montreal, Quebec, Canada.lld:pubmed
pubmed-article:2176862pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2176862pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:2176862pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2176862lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2176862lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2176862lld:pubmed